Tynor Hot and Cold Pack is a convenient device to provide hot fomentation or cold compress.
Hot fomentation of the injured or inflamed area enhances the threshold of pain and thus reduces the perception of pain. It has a synergistic effect along with pain relieving drugs. Raising temperature of the injured tissue also enhances the blood profusion and the healing process. Hot fomentation has a relaxing effect.
Cold compress helps in reduction of inflammation in injuries, protects by slowing the metabolic rate around the tissue, reduce oedema and bleeding. Cold compress helps in immediately lowering fever, in very high fever conditions. It can be used after an acute injury or surgical procedure.
No heat or cryo burns.
Requires no holding.
Reusable.
Easy application.
Appealing aesthetics.
Tynor Hot and Cold Pack Features
Multi functionality
Reduce swelling and odema at the site of injury.
Muscles spasm and pain.
Headache and minor injuries.
Versatile design
Can be used as either cold or hot pack.
Reusable in either hot & cold condition.
Temperature range - Can be used from 0 Cº to 75Cº.
Longer temperature retention time.
Fabric cover ensures no cryo burns or hot skin burns.
Physical features
Non-toxic, and biodegradable.
Gel remains soft and flexible upto 0 degree.
Durable, and puncture resistant.
Soft, "frost free" PVC cover.
Flexible conforms to the body contours.
Easy to clean and maintain.
Excellent workmanship.
Good aesthetics.
Elastic belt
Holds the pack against the body, No need to hold by hand.
Enhances convenience.
Tynor Hot and Cold Pack Measurements
Glass fiber syringe filters are biologically and chemically inert, high retentive depth filters with high dirt holding capacity. This syringe filters are made up 100% borosilicate glass fiber that is 100% binder free.
Tynor Hot and Cold Pack is a convenient device to provide hot fomentation or cold compress. Tynor Hot and Cold Pack is of multipurpose advantage. It is a convenient and effective approach for both hot as well as a cold therapy. Hot pack can be used for body ache, joint pain, etc., whereas a cold pack can be used for fever, sprains, fever, bleeding, etc. It is easy to use and maintains the temperature for a long period of time. It is available in 11.22 x 7.67 inch universal sizes.
Hot fomentation of the injured or inflamed area enhances the threshold of pain and thus reduces the perception of pain. It has a synergistic effect along with pain relieving drugs. Raising temperature of the injured tissue also enhances the blood profusion and the healing process. Hot fomentation has a relaxing effect.
Cold compress helps in reduction of inflammation in injuries, protects by slowing the metabolic rate around the tissue, reduce oedema and bleeding. Cold compress helps in immediately lowering fever, in very high fever conditions. It can be used after an acute injury or surgical procedure.
No heat or cryo burns.
Requires no holding.
Reusable.
Easy application.
Appealing aesthetics.
Tynor Hot and Cold Pack Features
Multi functionality
Reduce swelling and odema at the site of injury.
Muscles spasm and pain.
Headache and minor injuries.
Versatile design
Can be used as either cold or hot pack.
Reusable in either hot & cold condition.
Temperature range - Can be used from 0 Cº to 75Cº.
Longer temperature retention time.
Fabric cover ensures no cryo burns or hot skin burns.
Physical features
Non-toxic, and biodegradable.
Gel remains soft and flexible upto 0 degree.
Durable, and puncture resistant.
Soft, "frost free" PVC cover.
Flexible conforms to the body contours.
Easy to clean and maintain.
Excellent workmanship.
Good aesthetics.
Elastic belt
Holds the pack against the body, No need to hold by hand.
Enhances convenience.
Tynor
acute GC secretion during stress mobilizes peripheral amino acids from muscle as well as fatty acids and glycerol
from peripheral fat stores to provide substrates for glucose synthesis by the liver
chronically elevated GC levels
alter body fat distribution and increase visceral adiposity as well as metabolic abnormalities in a fashion reminiscent of
metabolic syndrome
This local production may
play an important role in the onset of obesity and insulin resistance.
In adipocytes, cortisol inhibits lipid mobilization in the presence of insulin, thus leading to triglyceride accumulation
and retention.
Since the density of GC receptors is higher in intra-abdominal (visceral) fat than in other fat depots, the
activity of cortisol leading to accumulation of fat is accentuated in visceral adipose tissue (24, 158), providing a mechanism by which excessive endogenous or exogenous GC lead to abdominal obesity and IR
obese patients generally have normal or subnormal
plasma cortisol concentrations
This may be explained by an increased intratissular/cellular concentration of cortisol in adipose tissues
Intracellular GC may be produced from recycling of GC metabolites such as cortisone in adipose tissues
Local GC recycling metabolism is mediated by 11β-hydroxysteroid dehydrogenase enzymes (11β-HSD1 and 11β-HSD2
Cortisol also increases 11β-HSD1 expression in human adipocytes
In humans, elevated 11β-HSD1 expression in visceral adipose tissue is also associated with obesity
even if obese patients generally have normal or subnormal plasma cortisol concentrations
(131, 158), triglyceride accumulation in visceral adipose tissue may be due, at least in part, to the local production of GC in insulin-
and GC-responsive organs such as adipose tissue, liver, and skeletal muscle
the energy supplied to rephosphorylate
adenosine diphosphate (ADP) to adenosine triphosphate (ATP) during and following intense
exercise is largely dependent on the amount of phosphocreatine (PCr) stored in the
muscle
Creatine is chemically known as a non-protein nitrogen
It is synthesized in the liver and pancreas from the amino acids arginine, glycine,
and methionine
Approximately 95% of the body's creatine is stored in skeletal muscle
About two thirds of the creatine found in skeletal muscle is stored as phosphocreatine
(PCr) while the remaining amount of creatine is stored as free creatine
The body breaks down about 1 – 2% of the creatine pool per day (about 1–2 grams/day)
into creatinine in the skeletal muscle
The magnitude of the increase in skeletal muscle creatine content is important because
studies have reported performance changes to be correlated to this increase
"loading" protocol. This protocol is characterized by ingesting approximately
0.3 grams/kg/day of CM for 5 – 7 days (e.g., ≃5 grams taken four times per day) and
3–5 grams/day thereafter [18,22]. Research has shown a 10–40% increase in muscle creatine and PCr stores using this
protocol
Additional research has reported that the loading protocol may only need to be 2–3
days in length to be beneficial, particularly if the ingestion coincides with protein
and/or carbohydrate
A few studies have reported protocols with no loading
period to be sufficient for increasing muscle creatine (3 g/d for 28 days)
Cycling protocols involve the consumption of "loading" doses for 3–5 days every 3
to 4 weeks
Most of these forms of creatine have been reported to be no
better than traditional CM in terms of increasing strength or performance
Recent studies do suggest, however, that adding β-alanine to CM
may produce greater effects than CM alone
These investigations indicate that the
combination may have greater effects on strength, lean mass, and body fat percentage;
in addition to delaying neuromuscular fatigue
creatine
phosphate has been reported to be as effective as CM at improving LBM and strength
Green et al. [24] reported that adding 93 g of carbohydrate to 5 g of CM increased total muscle creatine
by 60%
Steenge et al. [23] reported that adding 47 g of carbohydrate and 50 g of protein to CM was as effective
at promoting muscle retention of creatine as adding 96 g of carbohydrate.
It appears that combining CM with carbohydrate or carbohydrate and protein produces
optimal results
Studies suggest that increasing skeletal muscle creatine uptake may
enhance the benefits of training
Nearly 70% of these studies have
reported a significant improvement in exercise capacity,
Long-term CM supplementation appears to enhance the overall quality of training,
leading to 5 to 15% greater gains in strength and performance
Nearly all studies indicate that "proper" CM supplementation increases body mass
by about 1 to 2 kg in the first week of loading
short-term adaptations reported from
CM supplementation include increased cycling power, total work performed on the bench
press and jump squat, as well as improved sport performance in sprinting, swimming,
and soccer
Long-term adaptations when combining CM supplementation with training include increased
muscle creatine and PCr content, lean body mass, strength, sprint performance, power,
rate of force development, and muscle diameter
subjects taking CM typically gain about twice as much body
mass and/or fat free mass (i.e., an extra 2 to 4 pounds of muscle mass during 4 to
12 weeks of training) than subjects taking a placebo
The gains in muscle mass appear to be a result of an improved ability to perform
high-intensity exercise via increased PCr availability and enhanced ATP synthesis,
thereby enabling an athlete to train harder
there is no evidence to support the notion
that normal creatine intakes (< 25 g/d) in healthy adults cause renal dysfunction
no long-term side effects have been observed in athletes (up to 5 years),
One cohort of patients taking 1.5 – 3 grams/day of CM has been monitored since 1981
with no significant side effects
Treatment of exercise-associated hyponatremia with hypertonic IV infusion to correct plasma sodium levels is also a standard and accepted use of IV fluid infusions
athletes who present for medical care with hypernatremia who cannot tolerate oral fluids can benefit from IV fluids
Vaporization of sweat accounts for 80% of heat loss in hot, dry atmospheric conditions. This mechanism of water loss is the major contributor for exercise-associated dehydration
The rate of water loss can be quantified through measurement of sweat rate
Pre- and postexercise body weight measurements are the most common means to estimate overall water loss but are condition specific
It appears that 1% to 2% body weight loss is well tolerated by the exercising athlete
Dehydration, defined as greater than 2% loss of body weight, can negatively affect performance
In highly trained endurance athletes, plasma volume and sodium serum concentration were preserved despite a 5% body weight loss
In Ironman triathletes, dehydration to 5% body weight loss did not correlate with occurrence of medical complications
hydration should begin hours prior to exercise, especially if known deficits are present, and fluids should be consumed at a slow, steady rate, with 5 to 7 mL/kg taken 4 hours prior to exercise
Sodium concentration did not produce significant changes in the rate of absorption but was primarily dependent on carbohydrate concentration
Replacing 150% of body weight loss over 60 minutes has been tolerated without complications
IV treatment of severe dehydration (>7% body weight loss), exertional heat illness, nausea, emesis, or diarrhea, and in those who cannot ingest oral fluids for other reasons, is clinically indicated
A recent survey of the National Football League teams revealed that 75% (24 of 32) of the teams utilized IV infusion of fluids for prehydration in at least some otherwise healthy individuals
In the National Football League, an average of 1.5 L of normal saline was administered approximately 2.5 hours prior to competition
after 2 hours of exercise, the rectal temperature was 0.6° higher in the group not receiving IV infusion. Also, stroke volume and cardiac output were 11% to 16% lower in the control group versus the IV infusion group.
Recent evidence suggests the etiology of EAMC is related to muscle fatigue and neuronal excitability
no correlation between hydration status or electrolyte concentrations with EAMC
there may be a subset of muscle cramping that is associated with a loss of both body fluid and sodium
Glycerol is the primary agent for oral hyperhydration
elevation of plasma volume by 200 to 300 mL via dextran infusion resulted in 15% increase in stroke volume, 4% increase in VO2 max, and an increase in the exercise time to fatigue
Neither the tonicity nor mode of hydration resulted in improved speed of rehydration, greater fluid retention, or improved performance
There are beneficial anecdotal reports of EAMC treatment in elite and professional-level athletes with IV hydration during the course of an event
Plasma volume was better restored during rehydration with IV fluids at preexercise and 5 minutes of exercise. At 15 minutes, there was no difference between IV and oral rehydration
More rapid restoration of plasma volume was accomplished in the IV treatment group with no advantages over oral rehydration in physiological strain, heat tolerance, ratings of perceived effort, or thermal sensations
No difference was found in exercise time to exhaustion. IV and oral rehydration methods were equally effective. Heart rates were statistically higher in the oral rehydration group through 75 minutes of exercise, and there were higher increases in norepinephrine plasma concentrations
No significant differences between the groups were found for time to recovery, number of days with pain, number of days with stiffness, sleep disturbance, fatigue, rectal temperature, and loss of appetite
The current data suggest that IV rehydration is faster than oral
There may be physiological benefits of decreased heart rate and norepinephrine in athletes rehydrated via IV route
Postexercise blood 1 hour and 24 hours showed no differences in circulating myoglobin or creatine kinase
The use of IV fluid may be beneficial for a subset of fluid sensitive athletes
this should be reserved for high-level athletes with strong histories of symptoms in well-monitored settings.
Volume expanders may also be beneficial for some athletes
crucial role of the RAS in the development and maintenance of cancer
kidneys, which produce renin in response to decreased arterial pressure, reduced sodium in the distal tubule, or sympathetic nervous system activity via the β-adrenergic receptors
Renin is secreted from the juxtaglomerular cells into the bloodstream where it encounters angiotensinogen (AGN), normally produced by the liver
Renin catalyses the conversion of AGN to angiotensin I (ATI), which is quickly cleaved by angiotensin converting enzyme (ACE) to form angiotensin II (ATII)
ATII triggers the release of aldosterone from the adrenal glands, which stimulates reabsorption of sodium and water and thereby increases blood volume and blood pressure
ATII also acts on smooth muscle to cause vasoconstriction of the arterioles
ATII promotes the release of antidiuretic hormone from the posterior pituitary gland, which results in water retention and triggers the thirst reflex
ability of non-CSCs to ‘de-differentiate’ into CSCs due to epigenetic or environmental factors, which further increases the complexity of tumour biology and treatment
efficacy of RAS modulators on cancer in both cancer models and cancer patients
A localised (‘paracrine’) RAS mechanism has been identified in many types of cancers, and interruption of the control of the RAS is thought to be the basis for its role in cancer
Components of the RAS are expressed by these CSCs, supporting the hypothesis of the presence of a ‘paracrine RAS’ in regulating these CSCs
Renin is an enzyme normally released by the kidneys in response to falling arterial pressure
a study of GBM demonstrating overexpression of PRR coupled with the observation that inhibition of renin reduces cellular proliferation and promotes apoptosis
PRR has been found to be vital for normal Wnt signalling
A major focus of PRR research is its relationship with Wnt signalling
suggest a crucial role for PRR activation on the proliferation of CSCs, possibly via Wnt/β-catenin signalling, leading to carcinogenesis.
Angiotensin converting enzyme (ACE), also known as CD143, is the endothelial-bound peptidase which physiologically converts ATI to ATII
ACE is crucial in the regulation of blood pressure, angiogenesis and inflammation
results suggest that an overactive ACE promotes cancer growth and progression, and an inhibited or low-activity ACE may have cancer-protective effects
When bound to ATII or ATIII it causes vasoconstriction by stimulating the release of vasopressin, reabsorption of water and sodium by promoting secretion of aldosterone and insulin, fibrosis, cellular growth and migration, pro-inflammation, glucose release from the liver, increased plasma triglyceride concentration, and reduced gluconeogenesis
ATIIR1 is a G-protein-coupled receptor, with downstream signalling involved in vasodilation, hypertrophy and NF-κB activation leading to TNF-α and PAI-1 expression
ATIIR1 has well-documented links with cancer, with one study demonstrating its overexpression in ~20% of breast cancer patients
the effect of RAS dysregulation has been associated with increased VEGF expression and angiogenesis in cancers
In ovarian and cervical cancer, ATIIR1 overexpression has been shown to be an indicator of tumour invasiveness
administration of ATIIR1 blockers (ARBs) have been associated with reduced tumour size, reduction in tumour vascularisation, lower occurrence of metastases, and lower VEGF levels
Long foreskin
It was a situation in which he was always so shy when he opened his eyes even though he could easily go out easily, without pain, without tightening. Even when "greeting the flag" he kept hiding the ball under the glans or just poking out. Must have to wait for the hand of "big brother" to slide down to bear the road to see the world around.
When you have a clear understanding of the above concepts, the men of the race race to wonder, "Why is the foreskin of my friend not narrowed but why are my and my brother's bad luck?". The doctor asked for the correct answer, partly because of his bad luck, from birth to growing up, the foreskin was like that, "keep loving and protecting the foreskin." But it is not uncommon for other reasons to make men suffer because of foreskin:
First, we have to recall the untimely and improper foreskin effects of parents when children are young. It is these overly "anxious" actions of parents that have counterproductive and narrowed down the latter.
There are some autoimmune diseases, making the foreskin a fibrous day, loss of elasticity, gradually worsening, called BXO (balanitisxerotica obliterans) - a narrowed glans. This can also be interpreted as a form of glans, which can even cause narrowing of the urinary tract to lead to urinary retention.
Some cases of glans and foreskin have been repeatedly infected by microbiological agents (bacteria, viruses, fungi, etc.), which can be re-infected and non-stop treatment is also available. can lead to complications of fibrosis and secondary stenosis
Pharma Sust 250mg injections treat hypogonadism disorders in men, after the illness, impotence due to lack of hormones, menstrual symptoms in men such as reducing sexual pleasure and physiological activities.
Side effects:
The drug can cause erectile dysfunction, signs of excessive sexual stimulation, reduced sperm count, decreased volume of ejaculation, water & salt retention.
In pre-puberty boys: develop sex early, increase the frequency of erectile dysfunction, enlargement of the penis, and early growth of bone heads.
Study finds 2-4 resistance training episodes per week is optimal. Strength increased across the 3 time groups evaluated. The presence of inflammation is key in the interval between and # of workouts per week. Study found a point of plateau and diminishing returns.